The brain interface startup of Elon Musk Neurup ended a round of funding of $ 650 million, the company announced in a blog Monday. The fundraising of the E series included investors such as Ark Invest, Founders Fund, Sequoia Capital and Thrive Capital, among others.
Neuralink raised for the last time a financing tour of the 280 million dollars series in 2023, with An additional slice of $ 43 million added months later. Since then, Neuralink’s brain flea technology has made significant jumps.
Society says it has now conducted more human clinical trials, setting up its brain shavings in five people with severe paralysis. In May, Neuralink received Revolutionary device designation From the US Food and Drug Administration, a program intended to accelerate the development, evaluation and examination of processes for experimental technologies.
SEMAFOR has reported Last week, this last transaction values Neuralink at around $ 9 billion in pre-money.
